18:09:21 EDT Thu 24 Sep 2020
Enter Symbol
or Name
USA
CA



Medicure Inc (2)
Symbol MPH
Shares Issued 10,662,313
Close 2020-08-05 C$ 1.08
Recent Sedar Documents

Medicure to release Q2 2020 results Aug. 11

2020-08-05 12:30 ET - News Release

An anonymous director reports

MEDICURE Q2 2020 RESULTS AND CONFERENCE CALL DATES

Medicure Inc. will release its financial results for the quarter ended June 30, 2020, on Tuesday, Aug. 11, 2020. The second quarter financial statements will be made available at the company's website. Medicure will hold a conference call and webcast regarding the results on Wednesday, Aug. 12, 2020, at 7:30 a.m. Central Time (8:30 a.m. ET).

Conference call information

Topic:  Medicure's second quarter 2020 results

Call date:  Wednesday, Aug. 12, 2020

Time:  7:30 a.m. Central Time (8:30 a.m. ET)

Canada toll:  1-416-764-8659

North American toll-free:  1-888-664-6392

Passcode:  not required

Webcast:  visit the company's website

You may request international country-specific access information by e-mailing the company in advance. Management will accept and answer questions related to the financial results and operations during the question-and-answer period at the end of the conference call. A recording of the call will be available following the event at the company's website.

About Medicure Inc.

Medicure is a pharmaceutical company focused on the development and commercialization of therapies for the U.S. cardiovascular market. The present focus of the company is the marketing/distribution of the Aggrastat (tirofiban hydrochloride) injection and Zypitamag (pitavastatin) tablets in the United States, where they are sold through the company's U.S. subsidiary, Medicure Pharma Inc.

© 2020 Canjex Publishing Ltd. All rights reserved.